Several observations have identified ZEB1 as a regulator in pancreatic Kras-driven carcinogenesis, demonstrating that Zeb1 deletion in the KPC mouse model significantly delayed the onset of pancreatic cancer with a remarkably low number of α-SMA+ fibroblasts [77,78]. Here, ZEB1 is linked to familial pancreatic carcinoma.